Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Apertura Gene Therapy | 2022 | Series A | $67.0M | Newyork |
| Adela | 2026 | Convertible Note | $48.0M | Foster City |
| Ray Therapeutics | 2026 | Series B | Undisclosed | San Diego |
| AdaptHealth | 2026 | Post-IPO Debt | $1.1B | Phoenixville |
| Neomorph | 2026 | Series B | Undisclosed | San Diego |
| Hallux | 2022 | Venture - Series Unknown | $9.4M | Laguna Hills |
| Aurion Biotechnologies | 2022 | Venture - Series Unknown | $120.0M | Seattle |
| Stellar Health | 2022 | Venture - Series Unknown | Undisclosed | New York |
| Atlas Data Storage | 2026 | Seed | Undisclosed | South San Francisco |
| Jaguar Gene Therapy | 2022 | Venture - Series Unknown | Undisclosed | Lake Forest |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | Apertura Gene Therapy | Series A | $67.0M | Newyork, United Kingdom |
| 27 | Adela | Convertible Note | $48.0M | Foster City, United States |
| 28 | Ray Therapeutics | Series B | Undisclosed | San Diego, United States |
| 29 | AdaptHealth | Post-IPO Debt | $1.1B | Phoenixville, United States |
| 30 | Neomorph | Series B | Undisclosed | San Diego, United States |
| 31 | Hallux | Venture - Series Unknown | $9.4M | Laguna Hills, United States |
| 32 | Aurion Biotechnologies | Venture - Series Unknown | $120.0M | Seattle, United States |
| 33 | Stellar Health | Venture - Series Unknown | Undisclosed | New York, United States |
| 34 | Atlas Data Storage | Seed | Undisclosed | South San Francisco, United States |
| 35 | Jaguar Gene Therapy | Venture - Series Unknown | Undisclosed | Lake Forest, United States |
Apertura Gene Therapy is a biotechnology company that treats debilitating diseases with limited options.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
AdaptHealth is a provider of home healthcare equipment, medical supplies to the home and related services in the United States.
Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.
Hallux develops a new topical dosage form and route of administration for treating onychomycosis.
Aurion Biotechnologies is a clinical-stage biotech company.
Stellar Health empowers providers and practice staff to deliver high-quality care through real-time notifications and meaningful incentives.
Atlas Data Storage is an information technology company focused on data storage solutions.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Lomond Therapeutics creates pharmacological platforms that target escape mutations.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
ConcertoCare is a provider of at-home and comprehensive care for seniors and other adults.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications.
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
Perceive Pharma operates as a pharmaceutical company.
Axon Therapies develops a healthcare device with a neuromodulation approach to treat heart failure.
Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.
Actio Biosciences is a research center that develops drugs for rare diseases.
myLaurel offers in-home care, telemedicine, and extended follow-up services to reduce hospitalizations and re-admissions.
Cohere Health is a SaaS company that focuses on improving the efficiency and effectiveness of healthcare delivery.
Ascertain empowers care teams with AI to reduce admin burden and streamline operations for health systems, payers & providers.
Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.
Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.
Deerfield has invested in 160 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Deerfield's top investment sectors include Health Care, Biotechnology, Medical, Health Diagnostics, Therapeutics. The firm invests across 33 different industry categories.
Among tracked funding rounds, AdaptHealth received $1.1B in a Post-IPO Debt round. Deerfield's total known invested capital is $8.0B.
Deerfield's average investment size is $78.0M across its portfolio of 160 companies.
Recent Deerfield portfolio additions include Apertura Gene Therapy, Adela, Ray Therapeutics, AdaptHealth, Neomorph. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors